Stock Price
91.89
Daily Change
5.75%
Yearly
114.20%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 116.51 -2.15 -1.81% 11.08%
Acorda Therapeutics 2.86 -0.23 -7.44% 313.59%
Amgen 201.09 -2.88 -1.41% -10.55%
Anika Therapeutics 39.65 -0.92 -2.27% 3.61%
Arrowhead Research 72.02 -2.02 -2.73% 14.34%
AstraZeneca 8,411.00 -97.00 -1.14% 8.25%
BioCryst Pharmaceuticals 12.48 -0.02 -0.16% 143.27%
Biogen 242.90 -7.23 -2.89% -0.36%
Bristol-Myers Squibb 56.53 -0.28 -0.49% -10.34%
Clovis Oncology 3.20 -0.14 -4.19% -32.77%
Enanta Pharmaceuticals 91.89 5.00 5.75% 114.20%
Gilead Sciences 70.27 0.20 0.29% 17.06%
GlaxoSmithKline 1,510.80 -29.20 -1.90% 9.19%
Halozyme Therapeutics 33.85 -1.42 -4.03% -15.86%
Heron Therapeutics 9.41 -0.36 -3.68% -47.69%
Intercept Pharmaceuticals 17.10 -0.65 -3.66% -54.12%
Incyte Corp 68.38 1.64 2.46% -17.86%
Insmed 28.93 -1.68 -5.49% -27.31%
Ionis Pharmaceuticals 29.05 -0.71 -2.39% -42.18%
J&J 159.20 -1.04 -0.65% 10.56%
Karyopharm Therapeutics 7.27 -0.43 -5.58% -51.98%
Ligand Pharmaceuticals 156.85 -4.52 -2.80% 82.55%
Merck & Co 79.16 -3.12 -3.79% -0.88%
Marinus Pharmaceuticals 11.29 -0.54 -4.56% -22.88%
Neurocrine Biosciences 86.98 -0.88 -1.00% -8.98%
Novartis 74.72 -1.85 -2.42% -7.82%
Novavax 217.97 17.90 8.95% 73.42%
Pfizer 54.00 3.11 6.11% 45.04%
PTC Therapeutics 38.06 -1.35 -3.43% -40.52%
Roche Holding 358.60 -3.45 -0.95% 18.55%
Sarepta Therapeutics 79.62 -1.36 -1.68% -42.78%
Vertex Pharmaceuticals 183.59 -2.65 -1.42% -19.02%
Immunic Inc. 8.61 -0.58 -6.31% -50.94%

Indexes Price Day Year
US2000 2246 -85.52 -3.67% 21.06%
NASDAQ 15492 -353.57 -2.23% 26.92%

Enanta Pharmaceuticals
Enanta Pharmaceuticals, Inc. is a biotechnology company. The Company uses chemistry-driven approach and drug discovery capabilities. The Company is focused on discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. The Company has clinical candidates for the disease targets, including respiratory syncytial virus (RSV), hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH). It also conducts research in human metapneumovirus (hMPV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease-2019 (COVID-19). The Company has discovered glecaprevir, a protease inhibitor discovered and developed through its collaboration with AbbVie for the treatment of chronic hepatitis C virus (HCV). Glecaprevir is co-formulated as part of AbbVie’s direct-acting antiviral (DAA), a combination treatment for HCV infection under the tradenames: MAVYRET and MAVIRET.